Cost-effectiveness of Dalteparin vs Unfractionated heparin for the prevention of venous Thromboembolism in Critically Ill patients

Robert A. Fowler, Nicole Mittmann, William Geerts, Diane Heels-Ansdell, Michael K. Gould, Gordon Guyatt, Murray Krahn, Simon Finfer, Ruxandra Pinto, Brian Chan, Orges Ormanidhi, Yaseen Arabi, Ismael Qushmaq, Marcelo G. Rocha, Peter Dodek, Lauralyn McIntyre, Richard Hall, Niall D. Ferguson, Sangeeta Mehta, John C. MarshallChristopher James Doig, John Muscedere, Michael J. Jacka, James R. Klinger, Nicholas Vlahakis, Neil Orford, Ian Seppelt, Yoanna K. Skrobik, Sachin Sud, John F. Cade, Jamie Cooper, Deborah Cook

科研成果: 期刊稿件文章同行评审

48 引用 (Scopus)
源语言英语
页(从-至)2135-2145
页数11
期刊JAMA - Journal of the American Medical Association
312
20
DOI
出版状态已出版 - 11月 26 2014
已对外发布

!!!ASJC Scopus Subject Areas

  • 一般医学

指纹

探究 'Cost-effectiveness of Dalteparin vs Unfractionated heparin for the prevention of venous Thromboembolism in Critically Ill patients' 的科研主题。它们共同构成独一无二的指纹。

引用此